We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$99.9B
AUM Growth
+$8.57B
Cap. Flow
+$4.38B
Cap. Flow %
4.39%
Top 10 Hldgs %
13.65%
Holding
3,112
New
37
Increased
2,360
Reduced
269
Closed
57

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$246M
2
XOM icon
ExxonMobil
XOM
+$96.1M
3
AAPL icon
Apple
AAPL
+$62M
4
VZ icon
Verizon
VZ
+$58.6M
5
BA icon
Boeing
BA
+$52.6M

Sector Composition

Rank Sector Weight
1 Technology 14.76%
2 Financials 14.54%
3 Healthcare 12.7%
4 Industrials 11.05%
5 Consumer Discretionary 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
METC icon
3001
Ramaco Resources Class A
METC
$649M
$113K ﹤0.01%
+11,977
New +$127K
CLSD
3002
DELISTED
Clearside Biomedical
CLSD
$112K ﹤0.01%
933
VSLR
3003
DELISTED
VIVINT SOLAR, INC.
VSLR
$112K ﹤0.01%
39,652
+1,197
+3% +$3.59K
IMDZ
3004
DELISTED
Immune Design Corp.
IMDZ
$111K ﹤0.01%
16,243
LWAY icon
3005
Lifeway Foods
LWAY
$481M
$109K ﹤0.01%
10,100
BPTH
3006
DELISTED
Bio-Path Holdings Inc
BPTH
$109K ﹤0.01%
33
LUB
3007
DELISTED
Luby's Inc.
LUB
$108K ﹤0.01%
34,600
KONA
3008
DELISTED
Kona Grill, Inc.
KONA
$108K ﹤0.01%
17,119
CBIO
3009
Crescent Biopharma
CBIO
$626M
$107K ﹤0.01%
196
TPST icon
3010
Tempest Therapeutics
TPST
$14.6M
$107K ﹤0.01%
19
ALJJ
3011
DELISTED
ALJ Regional Holdings Inc
ALJJ
$107K ﹤0.01%
28,500
USAK
3012
DELISTED
USA Truck Inc
USAK
$105K ﹤0.01%
14,200
MRTX
3013
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$103K ﹤0.01%
19,648
+1,600
+9% +$8.77K
NMRX
3014
DELISTED
Numerex Corp
NMRX
$103K ﹤0.01%
21,400
LPCN icon
3015
Lipocine
LPCN
$17.6M
$102K ﹤0.01%
1,535
NDLS icon
3016
Noodles & Co
NDLS
$107M
$102K ﹤0.01%
2,196
+21
+1% +$708
RGLS
3017
DELISTED
Regulus Therapeutics
RGLS
$102K ﹤0.01%
515
TTNP
3018
DELISTED
Titan Pharmaceuticals
TTNP
$100K ﹤0.01%
8
GSOL
3019
DELISTED
Global Sources Ltd
GSOL
$99K ﹤0.01%
12,000
XMAX
3020
XMAX Inc
XMAX
$578M
$95K ﹤0.01%
2,288
CRK icon
3021
Comstock Resources
CRK
$3.94B
$94K ﹤0.01%
10,160
RELY
3022
DELISTED
Real Industry, Inc.
RELY
$94K ﹤0.01%
32,714
ABCD
3023
DELISTED
Cambium Learning Group, Inc.
ABCD
$89K ﹤0.01%
18,000
DCOY
3024
Decoy Therapeutics
DCOY
$2.09M
0
DALN
3025
DELISTED
DallasNews
DALN
$86K ﹤0.01%
3,495

Similar funds

Charles Schwab's Q1 2017 Portfolio in Review

As of Q1 2017, Charles Schwab held 3,112 positions worth $99.9B, up 9.4% from $91.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $4.38B of net new capital in Q1 2017, opening 37 new positions and adding to 2,360 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Chevron, an estimated $174M trimmed.

  • Charles Schwab's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
  • Charles Schwab added most to Home Depot in Q1 2017, an estimated $246M increase.
  • Charles Schwab's biggest Q1 2017 reduction was Chevron, cutting an estimated $174M.
  • Charles Schwab fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $85.4M.
  • Charles Schwab's ten largest holdings make up 14% of its $99.9B portfolio in Q1 2017.
  • Charles Schwab opened 37 new positions and closed 57 in Q1 2017.
  • Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $99.9B.

Based on Charles Schwab's 13F filing for Q1 2017, filed 15 May 2017.